Publicaciones en colaboración con investigadores/as de Centro de Investigación Biomédica en Red de Enfermedades Infecciosas (22)

2024

  1. Altered blood microbiome in patients with HCV-related Child-Pugh class B cirrhosis

    Journal of Infection and Public Health, Vol. 17, Núm. 10

  2. Editorial: Precision medicine in viral hepatitis: progress and prospects towards elimination

    Frontiers in Cellular and Infection Microbiology

  3. Longer ICU stay and invasive mechanical ventilation accelerate telomere shortening in COVID-19 patients 1 year after recovery

    Critical Care, Vol. 28, Núm. 1

  4. Low-level HIV-1 viremia affects T-cell activation and senescence in long-term treated adults in the INSTI era

    Journal of Biomedical Science, Vol. 31, Núm. 1

  5. MiRNome Profiling of Extracellular Vesicles in Patients with Severe COVID-19 and Identification of Predictors of Mortality

    Journal of Infectious Diseases, Vol. 230, Núm. 4, pp. 901-911

  6. Plasma metabolomic profile is near-normal in people with HIV on long-term suppressive antiretroviral therapy

    Frontiers in Cellular and Infection Microbiology, Vol. 14

2023

  1. A second update on mapping the human genetic architecture of COVID-19

    Nature

  2. Corrigendum to “PBMCs gene expression signature of advanced cirrhosis with high risk for clinically significant portal hypertension in HIV/HCV coinfected patients: A cross-control study” [Biomed. Pharmacother. 159 (2023) 114220] (Biomedicine & Pharmacotherapy (2023) 159, (S0753332223000082), (10.1016/j.biopha.2023.114220))

    Biomedicine and Pharmacotherapy

  3. Diagnostic Performance of the HCV Core Antigen Test To Identify Hepatitis C in HIV-Infected Patients: a Systematic Review and Meta-Analysis

    Journal of clinical microbiology, Vol. 61, Núm. 1, pp. e0133122

  4. Diagnostic performance of hepatitis C core antigen assay to identify active infections: A systematic review and meta-analysis

    Reviews in Medical Virology, Vol. 33, Núm. 3

  5. Dynamics of cellular senescence markers after HCV elimination spontaneously or by DAAs in people living with HIV

    Biomedicine and Pharmacotherapy, Vol. 162

  6. HCV spontaneous clearers showed low senescence profile in people living with HIV under long ART

    Journal of Medical Virology, Vol. 95, Núm. 7

  7. IL7RA rs10491434 polymorphism is related to spontaneous HIV infection control in naïve HIV-infected patients: A retrospective study

    Journal of Medical Virology, Vol. 95, Núm. 11

  8. IRF5-TNOP3 polymorphisms are associated with elite control of HIV infection: A retrospective study

    Journal of medical virology, Vol. 95, Núm. 6, pp. e28841

  9. Immunological and senescence biomarker profiles in patients after spontaneous clearance of hepatitis C virus: gender implications for long-term health risk

    Immunity and Ageing, Vol. 20, Núm. 1

  10. MicroRNA signature from extracellular vesicles of HCV/HIV co-infected individuals differs from HCV mono-infected

    Journal of Molecular Medicine, Vol. 101, Núm. 11, pp. 1409-1420

  11. PBMCs gene expression signature of advanced cirrhosis with high risk for clinically significant portal hypertension in HIV/HCV coinfected patients: A cross-control study

    Biomedicine and Pharmacotherapy, Vol. 159

  12. Predictive plasma biomarkers of long-term increase in hepatic steatosis index after HCV eradication in HIV/HCV-coinfected patients

    Biomedicine and Pharmacotherapy, Vol. 164

  13. Relative telomere length impact on mortality of COVID-19: Sex differences

    Journal of Medical Virology, Vol. 95, Núm. 1

  14. TNFAIP3-interacting protein 1 polymorphisms and their association with symptomatic human respiratory syncytial virus infection and bronchiolitis in infants younger than one year from South Africa: A case-control study

    International Journal of Infectious Diseases, Vol. 136, pp. 107-110